Eledon Pharmaceuticals (FRA:2TK) Beginning Cash Position : €19.01 Mil (As of Mar. 2025)

View and export this data going back to 2014. Start your Free Trial

What is Eledon Pharmaceuticals Beginning Cash Position?

Eledon Pharmaceuticals's Beginning Cash Position for the quarter that ended in Mar. 2025 was €19.01 Mil.

Eledon Pharmaceuticals's quarterly Beginning Cash Position declined from Sep. 2024 (€23.46 Mil) to Dec. 2024 (€6.45 Mil) but then increased from Dec. 2024 (€6.45 Mil) to Mar. 2025 (€19.01 Mil).

Eledon Pharmaceuticals's annual Beginning Cash Position declined from Dec. 2022 (€80.08 Mil) to Dec. 2023 (€51.73 Mil) and declined from Dec. 2023 (€51.73 Mil) to Dec. 2024 (€4.40 Mil).

Eledon Pharmaceuticals Beginning Cash Position Historical Data

The historical data trend for Eledon Pharmaceuticals's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eledon Pharmaceuticals Beginning Cash Position Chart

Eledon Pharmaceuticals Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Beginning Cash Position

Get a 7-Day Free Trial

7.23

101.06

80.08

51.73

4.40

Eledon Pharmaceuticals Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Beginning Cash Position	Get a 7-Day Free Trial															4.24	5.25	23.46	6.45	19.01

Eledon Pharmaceuticals Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Eledon Pharmaceuticals Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Eledon Pharmaceuticals's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Eledon Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Eledon Pharmaceuticals Inc (FRA:2TK) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

ELDN:USA 2TK:Germany

Address

19800 MacArthur Boulevard, Suite 250, Irvine, CA, USA, 92612

Website

https://www.eledon.com

Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets the CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and patients living with ALS. The company's compound in development is tegoprubart, an IgG1, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.

Eledon Pharmaceuticals Headlines

No Headlines